The abdomen generally produces less bruising than the thigh because it typically has a thicker fat layer, creating more distance between the needle and underlying blood vessels
Clinical trials show that patients average 2 to 5 pounds in the first 4 weeks of semaglutide therapy, depending on starting dose, adherence, and individual metabolism
In mechanistic studies, it has shown a strong affinity for human GIP receptors (4.23 + /0.23) compared to GLP-1 receptors (0.135 + /0.020) [48], leading to more effective reduction of hyperglycemia than other agonists of the GLP-1 receptor, and contributes to its therapeutic effectiveness
According to altRx's own disclosure, compounded GLP-1 medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality
Two ingredients
SURMOUNT-5: Tirzepatide proves benefit over semaglutide for obesity